| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |